Evidence map›Paper›PMID 19442115›Full record

ReviewCurrent drug targets2009

Structural insight into histone recognition by the ING PHD fingers.

Karen S Champagne, Tatiana G Kutateladze

Abstract readReview
In one paragraph

Review in Current drug targets, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. AnPeerJ · 2022
    Article
  13. Article
  14. Histone dynamics during DNA replication stress.Journal of biomedical science · 2021
    Review
  15. Is There a Histone Code for Cellular Quiescence?Frontiers in cell and developmental biology · 2021
    Review
  16. Trimethyllysine: From Carnitine Biosynthesis to Epigenetics.International journal of molecular sciences · 2020
    Review
  17. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Review
  18. Article
  19. Article
  20. Targeting epigenetics for cancer therapy.Archives of pharmacal research · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Karen S ChampagneDepartment of Pharmacology, University of Colorado Denver School of Medicine, Aurora, Colorado 80045, USA. Karen.Champagne@ucdenver.edu
Tatiana G Kutateladze

Funding

Membrane Targeting by PI-binding DomainsR01GM071424 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2009
$1.0M
Structural basis of signaling by ING2 PHDR01CA113472 · NCI · UNIVERSITY OF COLORADO DENVER · PI KUTATELADZE, TATIANA G · 2006 to 2010
$987k
The structural role of ING proteins in chromatin remodeling.F32GM083462 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI GLASS, KAREN CHAMPAGNE · 2008 to 2010
$112k
NCI NIH HHS CA113472NCI NIH HHS R01 CA113472NIGMS NIH HHS F32 GM083462NIGMS NIH HHS GM071424NIGMS NIH HHS R01 GM071424
6 · The paper itself

Abstract

The Inhibitor of Growth (ING) tumor suppressors are implicated in oncogenesis, control of DNA damage repair, cellular senescence and apoptosis. All members of the ING family contain unique amino-terminal regions and a carboxy-terminal plant homeodomain (PHD) finger. While the amino-terminal domains associate with a number of protein effectors including distinct components of histone deacetylase (HDAC) and histone acetyltransferase (HAT) complexes, the PHD finger binds strongly and specifically to histone H3 trimethylated at lysine 4 (H3K4me3). In this review we describe the molecular mechanism of H3K4me3 recognition by the ING1-5 PHD fingers, analyze the determinants of the histone specificity and compare the biological activities and structures within subsets of PHD fingers. The atomic-resolution structures of the ING PHD fingers in complex with a H3K4me3 peptide reveal that the histone tail is bound in a large and deep binding site encompassing nearly one-third of the protein surface. An extensive network of intermolecular hydrogen bonds, hydrophobic and cation-pi contacts, and complementary surface interactions coordinate the first six residues of the H3K4me3 peptide. The trimethylated Lys4 occupies an elongated groove, formed by the highly conserved aromatic and hydrophobic residues of the PHD finger, whereas the adjacent groove accommodates Arg2. The two grooves are connected by a narrow channel, the small size of which defines the PHD finger's specificity, excluding interactions with other modified histone peptides. Binding of the ING PHD fingers to H3K4me3 plays a critical role in regulating chromatin acetylation. The ING proteins function as tethering molecules that physically link the HDAC and HAT enzymatic complexes to chromatin. In this review we also highlight progress recently made in understanding the molecular basis underlying biological and tumorigenic activities of the ING tumor suppressors.

Indexed as

ChromatinHistonesHomeodomain ProteinsHumansNeoplasmsProtein BindingProtein Structure, TertiaryTumor Suppressor ProteinsChromatinHistonesHomeodomain ProteinsTumor Suppressor Proteins

Identifiers

PMID19442115
PMCPMC2740728

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.